Overview

Effect of Ondansetron for Withdrawal Symptoms

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
We hope to determine whether Ondansetron, an anti-nausea medication, works to help relieve withdrawal symptoms experienced while the patient is being weaned off opioid medications. This medication has shown anecdotal evidence of being affective for the treatment of withdrawal symptoms and we hope to determine whether this is affective.
Phase:
N/A
Details
Lead Sponsor:
Stanford University
Treatments:
Ondansetron